Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

A population pharmacokinetic model of polymyxin B based on prospective clinical data to inform dosing in hospitalized patients.

Autor: Hanafin PO; Division of Pharmacotherapy and Experimental Therapeutics, Eshelman School of Pharmacy, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA., Kwa A; Department of Pharmacy, Singapore General Hospital, Singapore, Singapore; Emerging Infectious Diseases, Duke-NUS Medical School, Singapore, Singapore., Zavascki AP; Infectious Diseases Service, Hospital Moinhos de Vento, Porto Alegre, Brazil; Department of Internal Medicine, Medical School, Universidade Federal, Do Rio Grande Do Sul, Porto Alegre, Brazil., Sandri AM; Infection Control Department, Hospital São Lucas da Pontifícia Universidade Católica Do Rio Grande Do Sul, Porto Alegre, Brazil., Scheetz MH; Department of Pharmacy Practice, Midwestern University Chicago College of Pharmacy, Downers Grove, IL, USA., Kubin CJ; New York-Presbyterian Hospital/Columbia University Irving Medical Center, New York, NY, USA., Shah J; Division of Infectious Diseases, Department of Internal Medicine, Columbia University Vagelos College of Physicians and Surgeons, New York, NY, USA., Cherng BPZ; Department of Infectious Diseases, Singapore General Hospital, Singapore, Singapore., Yin MT; Division of Infectious Diseases, Department of Internal Medicine, Columbia University Vagelos College of Physicians and Surgeons, New York, NY, USA., Wang J; Biomedicine Discovery Institute, Monash University, Clayton, Victoria, Australia., Wang L; Biomedicine Discovery Institute, Monash University, Clayton, Victoria, Australia., Calfee DP; Department of Medicine, Weill Cornell Medical College, New York, NY, USA., Bolon M; Department of Healthcare Epidemiology and Infection Prevention, Northwestern Memorial Hospital, Chicago, IL, USA; Department of Medicine, Division of Infectious Diseases, Northwestern University Feinberg School of Medicine, Chicago, IL, USA., Pogue JM; Department of Clinical Pharmacy, University of Michigan College of Pharmacy, Ann Arbor, MI, USA., Purcell AW; Biomedicine Discovery Institute, Monash University, Clayton, Victoria, Australia; Department of Biochemistry and Molecular Biology, Monash University, Clayton, Victoria, Australia., Nation RL; Drug Delivery, Disposition and Dynamics, Monash Institute of Pharmaceutical Sciences, Monash University, Parkville, Victoria, Australia., Li J; Biomedicine Discovery Institute, Monash University, Clayton, Victoria, Australia., Kaye KS; Division of Allergy, Immunology and Infectious Diseases, Rutgers Robert Wood Johnson Medical School, New Brunswick, NJ, USA. Electronic address: kk1116@rwjms.rutgers.edu., Rao GG; Division of Pharmacotherapy and Experimental Therapeutics, Eshelman School of Pharmacy, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA. Electronic address: gaurirao@live.unc.edu.

Publikováno v: Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases [Clin Microbiol Infect] 2023 Sep; Vol. 29 (9), pp. 1174-1181. Date of Electronic Publication: 2023 May 20.

Reply to Pai.

Autor: Landersdorfer CB; Centre for Medicine Use and Safety, Faculty of Pharmacy and Pharmaceutical Sciences, Monash University, Parkville, Victoria, Australia., Nation RL, Forrest A, Sandri AM, Zavascki AP, Li J

Publikováno v: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America [Clin Infect Dis] 2013 Dec; Vol. 57 (12), pp. 1786. Date of Electronic Publication: 2013 Sep 18.

Pharmacokinetics of polymyxin B in patients on continuous venovenous haemodialysis.

Autor: Sandri AM; Infectious Diseases Service, Hospital São Lucas da Pontifícia Universidade Católica do Rio Grande do Sul, Porto Alegre, Brazil., Landersdorfer CB, Jacob J, Boniatti MM, Dalarosa MG, Falci DR, Behle TF, Saitovitch D, Wang J, Forrest A, Nation RL, Zavascki AP, Li J

Publikováno v: The Journal of antimicrobial chemotherapy [J Antimicrob Chemother] 2013 Mar; Vol. 68 (3), pp. 674-7. Date of Electronic Publication: 2012 Nov 23.

Treatment of hepatitis B virus-associated nephropathy.

Autor: Elewa U; New Kasr Al-Aini Teaching Hospital, Cairo University, Egypt., Sandri AM, Kim WR, Fervenza FC

Publikováno v: Nephron. Clinical practice [Nephron Clin Pract] 2011; Vol. 119 (1), pp. c41-9; discussion c49. Date of Electronic Publication: 2011 Jun 15.